Ignite Creation Date:
2024-05-06 @ 6:43 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05768139
Status:
RECRUITING
Last Update Posted:
2024-05-16
First Post:
2023-03-01
Brief Title:
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Sponsor:
Scorpion Therapeutics Inc
Organization:
Scorpion Therapeutics Inc
Organization Data
Organization:
Scorpion Therapeutics Inc
Class:
INDUSTRY
Study ID:
STX-478-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Scorpion Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None